Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“NAM, in contrast, is a well reported and widely used sirtuin inhibitor31 and has been recently shown to inhibit NAD+-consuming activities in vivo24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In another study, NAAD was not detected in human blood prior to NR supplementation, while there was a ∼2,900% increase in NAAD baseline in healthy individuals taking single doses of up to 1 g NR (100, 300, and 1000 mg) [63].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
The cited source says what the claim attributes to it.
In the citing paper
“It is still unclear why NR administration increases NAD+ levels more than NAM and NA treatment [63], while NMN and NAM administration showed no difference in NAD levels in blood and liver [90].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“However, by LC-tandem MS and with the use of internal standards, the baseline concentrations of hepatic NMN and NAD+ were determined to be ∼2 and ∼1,000 pmol mg−1, respectively, rising to ∼10 and ∼4,000 pmol mg−1, respectively, 6 h after oral gavage of 185 mg kg−1 NR24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
The cited source says what the claim attributes to it.
In the citing paper
“This concept was established by a recent study in which orally administered equimolar NAM, NR and NA produced unique effects on hepatic NAD+ metabolism through distinct biosynthetic routes24.”
From NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells (2016) · cites this paper as [24]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Braidy, N., Poljak, A., Grant, R., Jayasena, T., Mansour, H., Chan‐Ling, T., Guillemin, G. J., Smythe, G. A., & Sachdev, P. S. (2013) · Biogerontology · doi:10.1007/s10522-013-9489-5 · Cited by 126
RetractedDose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
Research works printed but not linked: 1
- Altman, L. K. Who Goes First: The Story of Self-experimentation in Medicine University of California Press (1987).
Cited by
Items 101–200 of 696
Mitochondrial Dysfunction in the Transition from NASH to HCC
Léveillé, M., & Estall, J. L. (2019) · Metabolites · doi:10.3390/metabo9100233 · Cited by 100
Yasuda, I., Hasegawa, K., Sakamaki, Y., Muraoka, H., Kawaguchi, T., Kusahana, E., Ono, T., Kanda, T., Tokuyama, H., Wakino, S., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020081188 · Cited by 95
Roboon, J., Hattori, T., Ishii, H., Takarada‐Iemata, M., Nguyen, D. T., Heer, C. D., O’Meally, D., Brenner, C., Yamamoto, Y., Okamoto, H., et al. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15367 · Cited by 100
“The NR biosynthetic pathway is both unique and highly efficient in rodents and humans (Trammell et al., 2016) and corresponds to a biosynthetic pathway that is transcriptionally induced in heart failure (Diguet et al., 2018) and central brain injury (Vaur et al., 2017).”
BackgroundSelf-citationAddressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghanem, G. O. B., Wareham, L. K., & Calkins, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101261 · Cited by 112
“…of nicotinamide riboside (an NAD + precursor with superior bioavailability and pharmacokinetics compared to nicotinamide when delivered orally in humans and mice) (Trammell et al., 2016) in 125 POAG patients (Chinese Clinical Trial Registry, 1,900,021,998) (Leung et al., 2022; Mehmel et al., 2020).”
Safety and Tolerability of Nicotinamide Riboside in Heart Failure With Reduced Ejection Fraction
Wang, D. D., Airhart, S. E., Zhou, B., Shireman, L. M., Jiang, S., Rodriguez, C. M., Kirkpatrick, J. N., Shen, D. D., Tian, R., & O’Brien, K. D. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.06.012 · Cited by 103
“Left ventricular ejection fraction (most recent prior value), % 20 28 (11-40) 10 28 (14-39)”
BackgroundMetabolic Vulnerability in the Neurodegenerative Disease Glaucoma
Inman, D. M., & Harun-Or-Rashid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00146 · Cited by 88
“NR significantly increases NMN, NAM, and NAD+ levels in humans by the fourth dose of a daily 1,000mg intake, and maintains those increases up to 24 h after the seventh dose (Trammell et al., 2016).”
BackgroundCombined Metabolic Activators Accelerates Recovery in Mild‐to‐Moderate COVID‐19
Altay, O., Arif, M., Li, X., Yang, H., Aydın, M., Alkurt, G., Kim, W., Akyol, D., Zhang, C., Dinler‐Doganay, G., et al. (2021) · Advanced Science · doi:10.1002/advs.202101222 · Cited by 88
Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer’s disease model mice
Xie, X. M., Gao, Y., Zeng, M., Wang, Y., Wei, T.-F., Lu, Y., & Zhang, W. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0346-8 · Cited by 91
Dollerup, O. L., Trammell, S. A. J., Hartmann, B., Holst, J. J., Christensen, B., Møller, N., Gillum, M. P., Treebak, J. T., & Jessen, N. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-01081 · Cited by 77
Self-citationVaur, P., Brugg, B., Mericskay, M., Li, Z., Schmidt, M. S., Vivien, D., Orset, C., Jacotot, E. D., Brenner, C., & Duplus, E. (2017) · The FASEB Journal · doi:10.1096/fj.201700221rr · Cited by 92
“The humanoral availabilityofNR(33) suggests thepotential for testing NR in diseases and conditions of central neurodegeneration including Alzheimer’s disease, Parkinson’s disease, and traumatic brain injury.”
BackgroundSelf-citationTargeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment
Jin, J., Yan, P., Wang, D., Bai, L., Liang, H., Zhu, X., Zhu, H., Ding, C., Wei, H., & Wang, Y. (2025) · Nature Immunology · doi:10.1038/s41590-025-02178-8 · Cited by 107
“As an endogenous molecule that serves as a precursor to NAD + , NR is soluble and orally bioavailable, making it a safe and effective choice for in vivo NAD + replenishment 20,21 .”
Mateuszuk, Ł., Campagna, R., Kutryb-Zając, B., Kuś, K., Słominska, E. M., Smolenski, R. T., & Chlopicki, S. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114019 · Cited by 81
SIRT1 Regulation in Ageing and Obesity
Pardo, P. S., & Boriek, A. M. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111249 · Cited by 98
Therapeutic potential of boosting NAD+ in aging and age-related diseases
Aman, Y., Qiu, Y., Tao, J., & Fang, E. F. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.003 · Cited by 96
Antioxidant Alternatives in the Treatment of Amyotrophic Lateral Sclerosis: A Comprehensive Review
Carrera‐Juliá, S., Moreno, M. L., Barrios, C., Ortí, J. E. D. L. R., & Drehmer, E. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00063 · Cited by 93
Adipose tissue NAD + biology in obesity and insulin resistance: From mechanism to therapy
Yamaguchi, S., & Yoshino, J. (2017) · BioEssays · doi:10.1002/bies.201600227 · Cited by 92
Hamity, M. V., White, S. R., Walder, R. Y., Schmidt, M. S., Brenner, C., & Hammond, D. L. (2017) · Pain · doi:10.1097/j.pain.0000000000000862 · Cited by 80
Self-citationTannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 84
SIRT7: the seventh key to unlocking the mystery of aging
Raza, U., Tang, X., Liu, Z., & Liu, B. (2023) · Physiological Reviews · doi:10.1152/physrev.00044.2022 · Cited by 88
Antiaging effects of bioactive molecules isolated from plants and fungi
Martel, J., Ojcius, D. M., Ko, Y., Chang, C., & Young, J. D. (2019) · Medicinal Research Reviews · doi:10.1002/med.21559 · Cited by 81
NMR Metabolomics Methods for Investigating Disease
Gowda, G. A. N., & Raftery, D. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04606 · Cited by 91
Berven, H., Kverneng, S. U., Sheard, E., Søgnen, M., Geijerstam, S. A. A., Haugarvoll, K., Skeie, G. O., Dölle, C., & Tzoulis, C. (2023) · Nature Communications · doi:10.1038/s41467-023-43514-6 · Cited by 96
“Nicotinic acid adenine dinucleotide (NAAD) was also elevated as consistently observed in NR-supplementationstudies 26,28,33 .”
BackgroundResultInfluentialToward understanding genomic instability, mitochondrial dysfunction and aging
Fakouri, N. B., Hou, Y., Demarest, T. G., Christiansen, L. S., Okur, M. N., Mohanty, J. G., Croteau, D. L., & Bohr, V. A. (2019) · The FEBS Journal · doi:10.1111/febs.14663 · Cited by 77
BST1 regulates nicotinamide riboside metabolism via its glycohydrolase and base-exchange activities
Yaku, K., Palikhe, S., Izumi, H., Yoshida, T., Hikosaka, K., Hayat, F., Karim, M., Iqbal, T., Nitta, Y., Sato, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27080-3 · Cited by 76
Self-citationNicotinamide Adenine Dinucleotide Metabolism and Neurodegeneration
Pehar, M., Harlan, B. A., Killoy, K. M., & Vargas, M. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7145 · Cited by 78
“NR has recently been shown to be orally available and to safely boost NAD + levels in mice and humans (161).”
Cardioprotection by nicotinamide mononucleotide (NMN): Involvement of glycolysis and acidic pH
Nadtochiy, S. M., Wang, Y. T., Nehrke, K. W., Munger, J., & Brookes, P. S. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.06.007 · Cited by 77
NRH salvage and conversion to NAD+ requires NRH kinase activity by adenosine kinase
Yang, Y., Zhang, N., Zhang, G., & Sauve, A. A. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0194-9 · Cited by 75
Reduced nicotinamide mononucleotide is a new and potent NAD + precursor in mammalian cells and mice
Perez, R. Z., Tammaro, A., Schomakers, B. V., Scantlebery, A. M. L., Denis, S. W., Elfrink, H. L., Giroud‐Gerbetant, J., Cantó, C., López‐Leonardo, C., McIntyre, R. L., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202001826r · Cited by 83
Hu, L., Guo, Y., Song, L., Wen, H., Sun, N., Wang, Y., Qi, B., Liang, Q., Geng, J., Liu, X., et al. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.03.012 · Cited by 73
Aberrant NAD+ metabolism underlies Zika virus–induced microcephaly
Pang, H., Jiang, Y., Li, J., Wang, Y., Nie, M., Xiao, N., Wang, S., Song, Z., Ji, F., Chang, Y., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00437-0 · Cited by 83
Pham, T. X., Bae, M., Kim, M., Lee, Y., Hu, S., Kang, H., Park, Y., & Lee, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.009 · Cited by 76
Ear, P. H., Chadda, A., Gumusoglu, S. B., Schmidt, M. S., Vogeler, S., Malicoat, J., Kadel, J., Moore, M. M., Migaud, M. E., Stevens, H. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.01.007 · Cited by 72
“Supplementation of maternal chow with NR boosted blood NAD+ and NAM by 2-fold and increased levels of blood NAAD and MeNAM by 10-fold.”
BackgroundMethodInfluentialSelf-citationDiverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 77
Harlan, B. A., Killoy, K. M., Pehar, M., Liu, L., Auwerx, J. H., & Vargas, M. R. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113219 · Cited by 74
Keeping the balance in NAD metabolism
Strømland, Ø., Niere, M., Nikiforov, A. A., VanLinden, M. R., Heiland, I., & Ziegler, M. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180417 · Cited by 76
Aging Fits the Disease Criteria of the International Classification of Diseases
Khaltourina, D. A., Matveyev, Y., Alekseev, A., Cortese, F., & Ioviţă, A. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111230 · Cited by 85
Cortés‐Rojo, C., Vargas-Vargas, M. A., Olmos‐Orizaba, B. E., Rodríguez-Orozco, A. R., & Calderón‐Cortés, E. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165801 · Cited by 78
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes
Wu, J., Singh, K., Lin, A., Meadows, A. M., Wu, K., Shing, V., Bley, M., Hassanzadeh, S., Huffstutler, R. D., Schmidt, M. S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci139828 · Cited by 76
“tion immediately prior to LC-MS analysis (28).”
InfluentialSelf-citationDietary strategies with anti-aging potential: Dietary patterns and supplements
Duan, H., Pan, J., Guo, M., Li, J., Yu, L., & Fan, L. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111501 · Cited by 77
Bustamante, S., Jayasena, T., Richani, D., Gilchrist, R. B., Wu, L. E., Sinclair, D. A., Sachdev, P. S., & Braidy, N. (2017) · Metabolomics · doi:10.1007/s11306-017-1310-z · Cited by 70
2-Pyridone natural products as inhibitors of SARS-CoV-2 main protease
Forrestall, K. L., Burley, D. E., Cash, M. K., Pottie, I. R., & Darvesh, S. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109348 · Cited by 73
NAD + Redox Imbalance in the Heart Exacerbates Diabetic Cardiomyopathy
Chiao, Y. A., Chakraborty, A. D., Light, C. M., Tian, R., Sadoshima, J., Shi, X., Gu, H., & Lee, C. F. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.008170 · Cited by 69
Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter
Schmidt, M. S., & Brenner, C. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0085-0 · Cited by 64
Self-citationLiu, X., Zhang, Y., Deng, Y., Yang, L., Ou, W., Xie, M., Ding, L., Jiang, C., Yu, H., Li, Q., et al. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.12.015 · Cited by 66
Emerging potential benefits of modulating NAD + metabolism in cardiovascular disease
Matasic, D. S., Brenner, C., & London, B. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00409.2017 · Cited by 65
“Recent animal studies have indicated that equimolar oral NR is superior to NA and NAM in elevating NAD content in the liver (93).”
MethodInfluentialSelf-citationRaising NAD in Heart Failure: Time to Translate?
Walker, M. A., & Tian, R. (2018) · Circulation · doi:10.1161/circulationaha.117.032626 · Cited by 65
Lamb, D. A., Moore, J. H., Mesquita, P. H. C., Smith, M. A., Vann, C. G., Osburn, S. C., Fox, C. D., Lopez, H. L., Ziegenfuss, T. N., Huggins, K. W., et al. (2020) · Aging · doi:10.18632/aging.103218 · Cited by 62
“(NR) supplementation with the intent of increasing blood and tissue NAD levels has gained recent notoriety [40, 41].”
BackgroundImplications of NAD metabolism in pathophysiology and therapeutics for neurodegenerative diseases
Hikosaka, K., Yaku, K., Okabe, K., & Nakagawa, T. (2021) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1637504 · Cited by 62
Basse, A. L., Agerholm, M., Farup, J., Dalbram, E., Nielsen, J., Ørtenblad, N., Altıntaş, A., Ehrlich, A. M., Krag, T. O. B., Bruzzone, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101271 · Cited by 65
“A study with double-labeled NR demonstrated that orally administered NR only reached the skeletal muscle in the form of nicotinamide or NMN [11], and the bioavailability of NR for human skeletal muscle is debatable [96,97].”
BackgroundFukamizu, Y., Uchida, Y., Shigekawa, A., Sato, T., Kosaka, H., & Sakurai, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-18272-y · Cited by 69
The therapeutic perspective of NAD+ precursors in age-related diseases
Iqbal, T., & Nakagawa, T. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149590 · Cited by 77
Freeberg, K. A., Udovich, C. C., Martens, C. R., Seals, D. R., & Craighead, D. H. (2023) · The Journals of Gerontology Series A · doi:10.1093/gerona/glad106 · Cited by 80
Faivre, A., Katsyuba, E., Verissimo, T., Lindenmeyer, M. T., Rajaram, R. D., Naesens, M., Heckenmeyer, C., Mottis, A., Féraille, E., Cippà, P. E., et al. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa124 · Cited by 62
NAD+ metabolism as a target for metabolic health: have we found the silver bullet?
Connell, N. J., Houtkooper, R. H., & Schrauwen, P. (2019) · Diabetologia · doi:10.1007/s00125-019-4831-3 · Cited by 63
Aman, Y., Frank, J., Lautrup, S., Matysek, A., Niu, Z., Yang, G., Shi, L., Bergersen, L. H., Storm‐Mathisen, J., Rasmussen, L. J., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111194 · Cited by 67
“In particular, Trammell et al. reported that oral administration of NR (1000 mg/day for seven days) led to an increase in blood concentration of NAD + by 2.7-fold and 45.5-fold increase in nicotinic acid adenine dinucleotide (NAAD), an NAD + biosynthesis intermediate (Trammell et al., 2016).”
BackgroundInfluentialKropotov, A., Kulikova, V., Nerinovski, K., Yakimov, A., Svetlova, M., Solovjeva, L., Sudnitsyna, J., Migaud, M. E., Khodorkovskiy, M., Ziegler, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031391 · Cited by 57
“NR increases the lifespan of mice [29], while its administration to humans is non-toxic and leads to an increase in the level of NAD+ in the blood [30,31].”
BackgroundSelf-citationNAD(H) in mitochondrial energy transduction: implications for health and disease
Walker, M. A., & Tian, R. (2018) · Current Opinion in Physiology · doi:10.1016/j.cophys.2018.03.011 · Cited by 68
Manipulating fenestrations in young and old liver sinusoidal endothelial cells
Hunt, N. J., Lockwood, G. P., Warren, A., Mao, H., McCourt, P. A. G., Le Couteur, D. G., & Cogger, V. C. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00179.2018 · Cited by 58
Horimatsu, T., Blomkalns, A. L., Ogbi, M., Moses, M. M., Kim, D. S., Patel, S. Y., Gilreath, N., Reid, L. E., Benson, T. W., Pye, J., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz303 · Cited by 59
“In this regard, several recent studies indicate that nicotinamide riboside is highly bioavailable, safe and effective at elevating NADþ levels in adults.(46,47)”
BackgroundMolecular mechanisms of mitophagy and its roles in neurodegenerative diseases
Li, X., Huang, L., Lan, J., Feng, X., Li, P., Wu, L., & Peng, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105240 · Cited by 57
Niu, K., Bao, T., Gao, L., Ru, M., Li, Y., Jiang, L., Ye, C., Wang, S., & Wu, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.756243 · Cited by 60
“All the participants were instructed to take NMN (300 mg/day/person) (34) in warm water once a day after 30min of breakfast for a total of 90 days.”
BackgroundVignier, N., Chatzifrangkeskou, M., Rodríguez, B. M., Mericskay, M., Mougenot, N., Wahbi, K., Bonne, G., & Muchir, A. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy278 · Cited by 67
NAD+ and NAFLD – caution, causality and careful optimism
Dall, M., Hassing, A. S., & Treebak, J. T. (2021) · The Journal of Physiology · doi:10.1113/jp280908 · Cited by 61
“Found that hepatocytes are CD38-negative Trammell et al. 2016a NR (100–1000 mg for humans, 185 mg/kg body weight for gavage in mice and 500 mg/kg body weight for injections in mice) 24 h (humans), 12 h (mice with gavage), and 6 days (mice with injections) Humans (healthy men and women) and Mice (male C57BL/6J at 12 we…”
BackgroundInfluentialImpact of NAD+ metabolism on ovarian aging
Liang, J., Huang, F., Song, Z., Tang, R., Zhang, P., & Chen, R. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00398-w · Cited by 63
“Similarly, oral intake of NR increases NAD + levels in blood cells, displaying 2–3 times greater potency at raising ADPR compared to NAM [261].”
BackgroundSun, X., & Feinberg, M. W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.693067 · Cited by 58
Doped Graphene To Mimic the Bacterial NADH Oxidase for One-Step NAD + Supplementation in Mammals
Liu, X., Li, J., Zitolo, A., Gao, M., Jiang, J., Geng, X., Xie, Q., Wu, D., Zheng, H., Cai, X., et al. (2023) · Journal of the American Chemical Society · doi:10.1021/jacs.2c12336 · Cited by 56
Wang, X., Zhang, Z.-F., Zheng, G., Wang, A., Sun, C., Qin, S., Zhuang, J., Lu, J. L., Ma, D., & Zheng, Y. (2017) · Molecules · doi:10.3390/molecules22081315 · Cited by 64
“The NR dosage used in this study was based on the literature [54,55].”
MethodGaul, D. S., Weber, J., van Tits, L. J., Sluka, S. H. M., Pasterk, L., Reiner, M. F., Calatayud, N., Lohmann, C., Klingenberg, R., Pahla, J., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy036 · Cited by 56
A biosensor for measuring NAD+ levels at the point of care
Yu, Q., Pourmandi, N., Xue, L., Gondrand, C., Fabritz, S., Bardy, D., Patiny, L., Katsyuba, E., Auwerx, J., & Johnsson, K. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0151-7 · Cited by 55
Wang, X., He, H., Xiong, X., Zhou, S., Wang, W., Feng, L., Han, R., & Xie, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.668491 · Cited by 61
Clinical Evidence for Targeting NAD Therapeutically
Radenković, D., Reason, & Verdin, E. M. (2020) · Pharmaceuticals · doi:10.3390/ph13090247 · Cited by 62
“Both NMN and NR have received the most recent interest as promising future therapeutic strategies to raise NAD levels [8].”
BackgroundJing, R., Corbett, J., Cai, J., Beeson, G. C., Beeson, C., Chan, S. S. L., Dimmock, D., Lazcares, L., Geurts, A. M., Lemasters, J. J., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.036 · Cited by 60
“Although NR has been widely used in vivo to increase NAD+ levels because of its oral bioavailability (Cerutti et al., 2014; Zhang et al., 2016; Trammell et al., 2016), other NAD precursors, such as nicotinamide and NMN, are also known to be capable of elevating NAD+ levels and hold promise for the treatment of metabol…”
BackgroundGriffiths, H. B. S., Williams, C., King, S. J., & Allison, S. J. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190033 · Cited by 57
Pool, L., Wijdeveld, L. F. J. M., de Groot, N. M. S., & Brundel, B. J. J. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168463 · Cited by 56
NAD+: A key metabolic regulator with great therapeutic potential
Sultani, G., Samsudeen, A., Osborne, B., & Turner, N. A. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12508 · Cited by 61
NAD+ Deficits in Age-Related Diseases and Cancer
Garrido, A., & Djouder, N. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.06.001 · Cited by 56
Enzymology of extracellular NAD metabolism
Gasparrini, M., Sorci, L., & Raffaelli, N. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03742-1 · Cited by 58
“The presence of deamidated pyridine nucleosides and nucleotides in extracellular fluids has been poorly investigated so far, and contrasting data on their occurrence in human plasma have been reported [35, 45].”
BackgroundPotential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
Tovar‐Palacio, C., Noriega, L. G., & Mercado, A. (2022) · Nutrients · doi:10.3390/nu14030653 · Cited by 55
“A previous study with 12 healthy volunteers showed that NR alone, at doses ranging from 100 to 1000 mg, increased peripheral blood mononuclear cell NAD+ levels after 24 h [162].”
Pencina, K. M., Lavu, S., dos Santos, M. R., Beleva, Y. M., Cheng, M. S., Livingston, D. H., & Bhasin, S. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac049 · Cited by 56
Poljšak, B., Kovač, V., Špalj, S., & Milisav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032959 · Cited by 62
“7-fold in human blood in 12 subjects with only one dose of 1000 mg applied per os [81].”
BackgroundZhang, Y., Higgins, C. B., Tica, S., Adams, J. A., Sun, J., Kelly, S. C., Zong, X., Dietzen, D. J., Pietka, T., Ballentine, S. J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.07.007 · Cited by 56
Hyperglycemia-reduced NAD+ biosynthesis impairs corneal epithelial wound healing in diabetic mice
Li, Y., Li, J., Zhao, C., Yang, L., Qi, X., Wang, X., Zhou, Q., & Shi, W. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154402 · Cited by 53
Wang, Q., Zuurbier, C. J., Huhn, R., Torregroza, C., Hollmann, M. W., Preckel, B., van den Brom, C. E., & Weber, N. C. (2023) · Cells · doi:10.3390/cells12101432 · Cited by 51
“Surprisingly, few studies have examined NR as an NAD+ precursor in cardiac IRI studies, which is somewhat surprising given NR’s superiority in elevating NAD+ in humans [72].”
BackgroundEmerging strategies, applications and challenges of targeting NAD+ in the clinic
Zhang, J., Wang, H., Lautrup, S., Nilsen, H. L., Treebak, J. T., Watne, L. O., Selbæk, G., Wu, L. E., Omland, T., Pirinen, E., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00947-6 · Cited by 67
“Current evidence from clinical trials of NR and NMN has been largely reassuring, with no major adverse medical effects reported 204,209,221,222 .”
Heer, C. D., Sanderson, D. J., Voth, L. S., Alhammad, Y. M. O., Schmidt, M. S., Trammell, S. A. J., Perlman, S. M., Cohen, M. S., Fehr, A. R., & Brenner, C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.17.047480 · Cited by 50
Self-citationCircadian regulation of cardiac metabolism
Zhang, L., & Jain, M. K. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148276 · Cited by 51
“1172/JCI148276 level in the blood; however, whether the NAD+ level increases accordingly in the myocardium has yet to be examined (91, 92).”
BackgroundDemarest, T. G., Truong, G. T. D., Lovett, J., Mohanty, J. G., Mattison, J. A., Mattson, M. P., Ferrucci, L., Bohr, V. A., & Moaddel, R. (2019) · Analytical Biochemistry · doi:10.1016/j.ab.2019.02.019 · Cited by 48
“In RBCs, NAAD was the only metabolite that was below the linear range, which is consistent with a recent study indicating that NAAD is only detectable in human blood after treatment with the NAD+ precursor, nicotinamide riboside [3].”
BackgroundResultInfluentialPharmacology and Potential Implications of Nicotinamide Adenine Dinucleotide Precursors
She, J., Sheng, R., & Qin, Z. (2021) · Aging and Disease · doi:10.14336/ad.2021.0523 · Cited by 53
“Oral administration of NA has been shown to result in a two-fold increase in NAD levels in the liver along with an increase in the NAAD level [76, 79].”
BackgroundMethodResultInfluentialEffects of NAD+ precursor supplementation on glucose and lipid metabolism in humans: a meta-analysis
Zhong, O., Wang, J., Tan, Y., Lei, X., & Tang, Z. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00653-9 · Cited by 51
“In rodents, NR is more efficient in boosting NAD+ than NA and NAM [22], but the number of clinical studies on NR intervention is relatively low, and the evidence of NR’s benefit to human beings is limited.”
BackgroundOrr, M. E., Kotkowski, E., Ramirez, P., Bair‐Kelps, D., Liu, Q., Brenner, C., Schmidt, M. S., Fox, P. T., Larbi, A., Tan, C. T. Y., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00999-9 · Cited by 73
“Prior studies suggest that oral supplementation of NR is safe and well tolerated and boosts NAD+ and metabolites in adults [39–41].”
InfluentialSelf-citationRoles of NAD + in Health and Aging
Lautrup, S., Hou, Y., Fang, E. F., & Bohr, V. A. (2023) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041193 · Cited by 57
NAD+ and cardiovascular diseases
Lin, Q., Zuo, W., Liu, Y., Wu, K., & Liu, Q. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.01.012 · Cited by 54
Voth, L. S., O’Connor, J. J., Kerr, C. M., Doerger, E., Schwarting, N., Sperstad, P. D., Johnson, D. K., & Fehr, A. R. (2021) · Journal of Virology · doi:10.1128/jvi.00766-21 · Cited by 44
“ADP ribosylation is the posttranslational covalent addition of ADP-ribose to proteins by ADP-ribosyltransferases that utilize NAD1 as a substrate.”
BackgroundZainabadi, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.007 · Cited by 49
Obrador, E., Palmer, R. S., Marchio, P., López‐Blanch, R., Jihad-Jebbar, A., Rivera, P., Vallés, S. L., Banacloche, S., Alcácer, J., Colomer, N., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02188-7 · Cited by 49
“NR, a pyridine-nucleoside form of vitamin B3, is a precursor to NAD + with superior pharmacokinetic profile relative to other forms of B3 (nicotinic acid and nicotinamide) [89].”
BackgroundApigenin: a natural molecule at the intersection of sleep and aging
Kramer, D. J., & Johnson, A. A. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1359176 · Cited by 61
Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns
Bhasin, S., Seals, D. R., Migaud, M. E., Musi, N., & Baur, J. A. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad019 · Cited by 54
Self-citationZhang, C., Björnson, E., Arif, M., Tebani, A., Lovrić, A., Benfeitas, R., Özcan, M., Juszczak, K., Kim, W., Kim, J. T., et al. (2020) · Molecular Systems Biology · doi:10.15252/msb.209495 · Cited by 44
“Trammell et al (Trammell et al, 2016) supplemented 1 g/day NR for 7 days to one subject.”
BackgroundStocks, B., Ashcroft, S. P., Joanisse, S., Dansereau, L. C., Koay, Y. C., Elhassan, Y., Lavery, G. G., Quek, L., O’Sullivan, J., Philp, A. M., et al. (2021) · The Journal of Physiology · doi:10.1113/jp280825 · Cited by 48
“Studies investigating NR supplementation in humans are in their infancy (Trammell et al. 2016; Airhart et al. 2017; Dellinger et al. 2017; Dollerup et al. 2018, 2019, 2020; Martens et al. 2018; Elhassan et al. 2019; Remie et al. 2020).”
BackgroundResultInfluentialNoninvasive imaging and quantification of bile salt hydrolase activity: From bacteria to humans
Khodakivskyi, P. V., Lauber, C. L., Yevtodiyenko, A., Bazhin, A. A., Bruce, S., Ringel‐Kulka, T., Ringel, Y., Bétrisey, B., Torres, J., Hu, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.aaz9857 · Cited by 48
Metadata
- Authors
- Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C.
- Affiliations
- University of Iowa (US)
- Queen's University Belfast (GB)
- ChromaDex (United States) (US)
- Corresponding author
- Brenner, Charles
- ORCID
- Venue
- Nature Communications
- Published
- 2016-10-10
- Volume
- 7
- Issue
- 1
- Pages
- 12948-12948
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5062546
- OpenAlex
- W2530388030
- Cited by
- 697
- References
- 57
- Citations by year
- 2026: 73 · 2025: 72 · 2024: 63 · 2023: 73 · 2022: 80 · 2021: 89 · 2020: 73 · 2019: 70 · 2018: 58 · 2017: 40 · 2016: 2
- FWCI
- 32.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
- Funders
- Roy J. Carver Charitable Trust
- National Institutes of Health
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council (BB/N001842/1)
- National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
- National Heart, Lung, and Blood Institute (R01HL108379)
- National Institute of General Medical Sciences (T32GM008629)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- nicotinamide riboside, NAD+ metabolism, oral bioavailability, pharmacokinetics, nicotinic acid, nicotinamide, dose-dependent effects
- MeSH terms
- Administration, Oral, Animals, Biological Availability, Humans, Leukocytes, Mononuclear, Liver, Male, Mice, Inbred C57BL, Middle Aged, NAD, Niacinamide, Pyridinium Compounds, Vitamins, Biomarkers, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.